Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 6735-6740, December 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Correa, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Correa, P.

Human Gastric Carcinogenesis: A Multistep and Multifactorial Process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention1

Pelayo Correa

Department of Pathology, Louisiana State University Medical Center, New Orleans, Louisiana 70112-1393

Evidence from pathology and epidemiology studies has been provided for a human model of gastric carcinogenesis with the following sequential stages: chronic gastritis; atrophy; intestinal metaplasia; and dysplasia. The initial stages of gastritis and atrophy have been linked to excessive salt intake and infection with Helicobacter pylori. The intermediate stages have been associated with the ingestion of ascorbic acid and nitrate, determinants of intragastric nitrosation. The final stages have been linked with the supply of β-carotene and with excessive salt intake. Nitrosating agents are candidate carcinogens and could originate in the gastric cavity or in the inflammatory infiltrate.

1 Presented at the 83rd Annual Meeting of the American Association for Cancer Research, May 22, 1992, San Diego, CA. The work on which a substantial portion of this American Cancer Society lecture is based was supported by Grant P01-CA28842 from the National Cancer Institute, NIH, and represents a collaborative effort with other investigators in the United States and Colombia.

Received 9/10/92. Accepted 10/ 7/92.




This article has been cited by other articles:


Home page
Therapeutic Advances in GastroenterologyHome page
R. M. Peek Jr
Review: Prevention of gastric cancer: When is treatment of Helicobacter pylori warranted?
Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 19 - 31.
[Abstract] [PDF]


Home page
GutHome page
A Larghi, P G Lecca, and G Costamagna
High-resolution narrow band imaging endoscopy
Gut, July 1, 2008; 57(7): 976 - 986.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Gu, L. Yang, Q. Sun, B. Zhou, N. Tang, R. Cong, Y. Zeng, and B. Wang
Gly82Ser Polymorphism of the Receptor for Advanced Glycation End Products Is Associated with an Increased Risk of Gastric Cancer in a Chinese Population
Clin. Cancer Res., June 1, 2008; 14(11): 3627 - 3632.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Chatterjee, E. Sabo, R. Tavares, and M. B. Resnick
Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome
Clin. Cancer Res., May 15, 2008; 14(10): 2994 - 3001.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Yeh, K. M. Kuntz, M. Ezzati, C. Hur, C. Y. Kong, and S. J. Goldie
Development of an Empirically Calibrated Model of Gastric Cancer in Two High-Risk Countries
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1179 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Yanaoka, M. Oka, C. Mukoubayashi, N. Yoshimura, S. Enomoto, M. Iguchi, H. Magari, H. Utsunomiya, H. Tamai, K. Arii, et al.
Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 838 - 845.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. H. Argent, R. J. Thomas, F. Aviles-Jimenez, D. P. Letley, M. C. Limb, E. M. El-Omar, and J. C. Atherton
Toxigenic Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives, and H. pylori Virulence Evolves in These Families
Clin. Cancer Res., April 1, 2008; 14(7): 2227 - 2235.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Ohnishi, H. Yuasa, S. Tanaka, H. Sawa, M. Miura, A. Matsui, H. Higashi, M. Musashi, K. Iwabuchi, M. Suzuki, et al.
Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse
PNAS, January 22, 2008; 105(3): 1003 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Con, R. Con-Wong, G. R. Con-Chin, V. G. Con-Chin, H. Takeuchi, A. L. Valerin, G. Echandi, F. Mena, F. Brenes, N. Yasuda, et al.
Serum Pepsinogen Levels, Helicobacter pylori CagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa Rica
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2631 - 2636.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A C de Vries, G A Meijer, C W N Looman, M K Casparie, B E Hansen, N C T van Grieken, and E J Kuipers
Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands
Gut, December 1, 2007; 56(12): 1665 - 1670.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Ohtani, A. Garcia, A. B. Rogers, Z. Ge, N. S. Taylor, S. Xu, K. Watanabe, R. P. Marini, M. T. Whary, T. C. Wang, et al.
Protective role of 17 -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice
Carcinogenesis, December 1, 2007; 28(12): 2597 - 2604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zavros, M. Waghray, A. Tessier, L. Bai, A. Todisco, D. L. Gumucio, L. C. Samuelson, A. Dlugosz, and J. L. Merchant
Reduced Pepsin A Processing of Sonic Hedgehog in Parietal Cells Precedes Gastric Atrophy and Transformation
J. Biol. Chem., November 16, 2007; 282(46): 33265 - 33274.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Plummer, L.-J. van Doorn, S. Franceschi, B. Kleter, F. Canzian, J. Vivas, G. Lopez, D. Colin, N. Munoz, and I. Kato
Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions
J Natl Cancer Inst, September 5, 2007; 99(17): 1328 - 1334.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
T. Tsukamoto, T. Mizoshita, and M. Tatematsu
Animal Models of Stomach Carcinogenesis
Toxicol Pathol, August 1, 2007; 35(5): 636 - 648.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S. Hansen, S. E. Vollset, M. H Derakhshan, V. Fyfe, K. K Melby, S. Aase, E. Jellum, and K. E L McColl
Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status
Gut, July 1, 2007; 56(7): 918 - 925.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Suzuki, H. Cullings, S. Fujiwara, N. Hattori, S. Matsuura, M. Hakoda, M. Akahoshi, K. Kodama, and E. Tahara
Low-Positive Antibody Titer against Helicobacter pylori Cytotoxin-Associated Gene A (CagA) May Predict Future Gastric Cancer Better Than Simple Seropositivity against H. pylori CagA or against H. pylori
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1224 - 1228.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. T. Loh, V. J. Torres, and T. L. Cover
Regulation of Helicobacter pylori cagA Expression in Response to Salt
Cancer Res., May 15, 2007; 67(10): 4709 - 4715.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-C. Lee, J.-T. Lin, H.-M. Wu, T.-Y. Liu, M.-F. Yen, H.-M. Chiu, H.-P. Wang, M.-S. Wu, and T. Hsiu-Hsi Chen
Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Gottschalg, G. B. Scott, P. A. Burns, and D. E.G. Shuker
Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer
Carcinogenesis, February 1, 2007; 28(2): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Plummer, J. Vivas, G. Lopez, J. C. Bravo, S. Peraza, E. Carillo, E. Cano, D. Castro, O. Andrade, V. Sanchez, et al.
Chemoprevention of Precancerous Gastric Lesions With Antioxidant Vitamin Supplementation: A Randomized Trial in a High-Risk Population
J Natl Cancer Inst, January 17, 2007; 99(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G M Naylor, T Gotoda, M Dixon, T Shimoda, L Gatta, R Owen, D Tompkins, and A Axon
Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients
Gut, November 1, 2006; 55(11): 1545 - 1552.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
H. M. S. Algood and T. L. Cover
Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses
Clin. Microbiol. Rev., October 1, 2006; 19(4): 597 - 613.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Kamangar, C. Cheng, C. C. Abnet, and C. S. Rabkin
Interleukin-1B Polymorphisms and Gastric Cancer Risk--A Meta-analysis.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1920 - 1928.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. K. Leung, E. K.W. Ng, F. K.L. Chan, W. Y. Chan, K.-f. Chan, A. C.M. Auyeung, C. C.H. Lam, J. Y.W. Lau, and J. J.Y. Sung
Effects of Long-term Rofecoxib on Gastric Intestinal Metaplasia: Results of a Randomized Controlled Trial
Clin. Cancer Res., August 1, 2006; 12(15): 4766 - 4772.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Sasazuki, M. Inoue, M. Iwasaki, T. Otani, S. Yamamoto, S. Ikeda, T. Hanaoka, S. Tsugane, and for the Japan Public Health Center Study Group
Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1341 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. N. Weck and H. Brenner
Prevalence of Chronic Atrophic Gastritis in Different Parts of the World.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1083 - 1094.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
X-X He, J Yang, Y-W Ding, W Liu, Q-Y Shen, and H H-X Xia
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis
Gut, June 1, 2006; 55(6): 797 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
B. Ferreira, N. T. Marcos, L. David, J. Nakayama, and C. A. Reis
Terminal {alpha}1,4-linked N-acetylglucosamine in Helicobacter pylori-associated Intestinal Metaplasia of the Human Stomach and Gastric Carcinoma Cell Lines.
J. Histochem. Cytochem., May 1, 2006; 54(5): 585 - 591.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Aoi, H Marusawa, T Sato, T Chiba, and M Maruyama
Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia.
Gut, April 1, 2006; 55(4): 588 - 589.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
Y. Oishi, Y. Kiyohara, M. Kubo, K. Tanaka, Y. Tanizaki, T. Ninomiya, Y. Doi, K. Shikata, K. Yonemoto, T. Shirota, et al.
The Serum Pepsinogen Test as a Predictor of Gastric Cancer: The Hisayama Study
Am. J. Epidemiol., April 1, 2006; 163(7): 629 - 637.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. C. Cunningham, F. Kamangar, M. P. Kim, S. Hammoud, R. Haque, C. A. Iacobuzio-Donahue, A. Maitra, R. Ashfaq, S. Hustinx, R. E. Heitmiller, et al.
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 281 - 287.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E M El-Omar
Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection
Gut, February 1, 2006; 55(2): 144 - 146.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. K. Leung, E. K.W. Ng, W. Y. Chan, A. C.M. Auyeung, K.-f. Chan, C. C.H. Lam, F. K.L. Chan, J. Y.W. Lau, and J. J.Y. Sung
Risk Factors Associated with the Development of Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2982 - 2986.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. B. Rogers, N. S. Taylor, M. T. Whary, E. D. Stefanich, T. C. Wang, and J. G. Fox
Helicobacter pylori but not High Salt Induces Gastric Intraepithelial Neoplasia in B6129 Mice
Cancer Res., December 1, 2005; 65(23): 10709 - 10715.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Goto, T. Ando, H. Goto, and N. Hamajima
No Association Between EGF Gene Polymorphism and Gastric Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2454 - 2456.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Fan, J. Li, B. Dong, and X. Huang
Expression of Cdx2 and Hepatocyte Antigen in Gastric Carcinoma: Correlation with Histologic Type and Implications for Prognosis
Clin. Cancer Res., September 1, 2005; 11(17): 6162 - 6170.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M.-S. Wu, C.-J. Chen, and J.-T. Lin
Host-Environment Interactions: Their Impact on Progression from Gastric Inflammation to Carcinogenesis and on Development of New Approaches to Prevent and Treat Gastric Cancer
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1878 - 1882.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J Chen, C Rocken, J Hoffmann, S Kruger, U Lendeckel, A Rocco, S Pastorekova, P Malfertheiner, and M P A Ebert
Expression of carbonic anhydrase 9 at the invasion front of gastric cancers
Gut, July 1, 2005; 54(7): 920 - 927.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. I. Sarela, N. Scott, C. S. Verbeke, J. I. Wyatt, S. P. L. Dexter, H. M. Sue-Ling, and P. J. Guillou
Diagnostic Variation and Outcome for High-Grade Gastric Epithelial Dysplasia
Arch Surg, July 1, 2005; 140(7): 644 - 649.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Ohyauchi, A Imatani, M Yonechi, N Asano, A Miura, K Iijima, T Koike, H Sekine, S Ohara, and T Shimosegawa
The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population
Gut, March 1, 2005; 54(3): 330 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Rieder, A. J. Tessier, X. T. Qiao, B. Madison, D. L. Gumucio, and J. L. Merchant
Helicobacter-induced Intestinal Metaplasia in the Stomach Correlates with Elk-1 and Serum Response Factor Induction of Villin
J. Biol. Chem., February 11, 2005; 280(6): 4906 - 4912.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. Niwa, Y. Ikehara, H. Nakanishi, H. Tanaka, K.-i. Inada, T. Tsukamoto, M. Ichinose, and M. Tatematsu
Mixed Gastric- and Intestinal-type Metaplasia Is Formed by Cells with Dual Intestinal and Gastric Differentiation
J. Histochem. Cytochem., January 1, 2005; 53(1): 75 - 85.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Mutoh, S Sakurai, K Satoh, H Osawa, T Tomiyama, H Kita, T Yoshida, K Tamada, H Yamamoto, N Isoda, et al.
Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma
Gut, January 1, 2005; 54(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. T. Nam, K.-B. Hahm, S.-Y. Oh, M. Yeo, S.-U. Han, B. Ahn, Y.-B. Kim, J. S. Kang, D. D. Jang, K.-H. Yang, et al.
The Selective Cyclooxygenase-2 Inhibitor Nimesulide Prevents Helicobacter pylori-Associated Gastric Cancer Development in a Mouse Model
Clin. Cancer Res., December 1, 2004; 10(23): 8105 - 8113.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Cui, T. J. Koh, D. Chen, C.-M. Zhao, S. Takaishi, G. J. Dockray, A. Varro, A. B. Rogers, J. G. Fox, and T. C. Wang
Overexpression of Glycine-Extended Gastrin Inhibits Parietal Cell Loss and Atrophy in the Mouse Stomach
Cancer Res., November 15, 2004; 64(22): 8160 - 8166.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Mandell, A. P. Moran, A. Cocchiarella, J. Houghton, N. Taylor, J. G. Fox, T. C. Wang, and E. A. Kurt-Jones
Intact Gram-Negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus Bacteria Activate Innate Immunity via Toll-Like Receptor 2 but Not Toll-Like Receptor 4
Infect. Immun., November 1, 2004; 72(11): 6446 - 6454.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-M. Yuan, R. K. Ross, Y.-T. Gao, Y.-H. Qu, X.-D. Chu, and M. C. Yu
Prediagnostic Levels of Serum Micronutrients in Relation to Risk of Gastric Cancer in Shanghai, China
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1772 - 1780.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Mutoh, S. Sakurai, K. Satoh, K. Tamada, H. Kita, H. Osawa, T. Tomiyama, Y. Sato, H. Yamamoto, N. Isoda, et al.
Development of Gastric Carcinoma from Intestinal Metaplasia in Cdx2-transgenic Mice
Cancer Res., November 1, 2004; 64(21): 7740 - 7747.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-G. Xi, K.-Y. Ding, X.-L. Su, D.-F. Chen, W.-C. You, Y. Shen, and Y. Ke
p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions
Carcinogenesis, November 1, 2004; 25(11): 2201 - 2206.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Mutoh, S Sakurai, K Satoh, H Osawa, Y Hakamata, T Takeuchi, and K Sugano
Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice
Gut, October 1, 2004; 53(10): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
W J Lee, W Lijinsky, E F Heineman, R S Markin, D D Weisenburger, and M H Ward
Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus
Occup. Environ. Med., September 1, 2004; 61(9): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
W K Leung, S-R Lin, J Y L Ching, K-F To, E K W Ng, F K L Chan, J Y W Lau, and J J Y Sung
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication
Gut, September 1, 2004; 53(9): 1244 - 1249.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. H. Weisburger
Dietary Risk Factors for Gastric Carcinoma
JAMA, April 7, 2004; 291(13): 1564 - 1564.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. S.P. Ladeira, M. A.M. Rodrigues, D. M.F. Salvadori, D. M.M. Queiroz, and D. V. Freire-Maia
DNA Damage in Patients Infected by Helicobacter pylori
Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 631 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Dinis-Ribeiro, C Lopes, A da Costa-Pereira, M Guilherme, J Barbosa, H Lomba-Viana, R Silva, and L Moreira-Dias
A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia
J. Clin. Pathol., February 1, 2004; 57(2): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E J Kuipers, G F Nelis, E C Klinkenberg-Knol, P Snel, D Goldfain, J J Kolkman, H P M Festen, J Dent, P Zeitoun, N Havu, et al.
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial
Gut, January 1, 2004; 53(1): 12 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R Malekzadeh, M Sotoudeh, M H Derakhshan, J Mikaeli, A Yazdanbod, S Merat, A Yoonessi, M Tavangar, B A. Abedi, R Sotoudehmanesh, et al.
Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran
J. Clin. Pathol., January 1, 2004; 57(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z.-W. Zhang, N. J. Laurence, A. Hollowood, P. Newcomb, M. Moorghen, J. Gupta, R. Feakins, M. J. G. Farthing, D. Alderson, and J. Holly
Prognostic Value of TP53 Codon 72 Polymorphism in Advanced Gastric Adenocarcinoma
Clin. Cancer Res., January 1, 2004; 10(1): 131 - 135.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. H. Wang, J. Q. Huang, G. F. Zheng, S. K. Lam, J. Karlberg, and B. C.-Y. Wong
Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis
J Natl Cancer Inst, December 3, 2003; 95(23): 1784 - 1791.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Z-R Zeng, P-J Hu, S Hu, R-P Pang, M-H Chen, M Ng, and J J Y Sung
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China
Gut, December 1, 2003; 52(12): 1684 - 1689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Mills, N. Andersson, T. S. Stappenbeck, C. C. M. Chen, and J. I. Gordon
Molecular Characterization of Mouse Gastric Zymogenic Cells
J. Biol. Chem., November 14, 2003; 278(46): 46138 - 46145.
[Abstract] [Full Text] [PDF]